TATFAR was created in 2009 to address the urgent threat of antimicrobial resistance (AMR). TATFAR’s technical experts from Canada, the European Union (EU), Norway, the United Kingdom, and the United States collaborate and share best practices to strengthen domestic and global efforts to combat AMR.
The Centers for Disease Control and Prevention (CDC) currently serves as the secretariat for TATFAR, providing administrative support and maintaining the website for the taskforce.
U.S. representatives to TATFAR include the U.S. Department of Health and Human Services (co-chair), NIH (NIAID), CDC, the Food and Drug Administration, the Biomedical Advanced Research and Development Authority, the U.S. Department of Agriculture, the U.S. Department of Defense, and the Environmental Protection Agency.
Main Areas of Focus
TATFAR’s goal is to improve cooperation between the United States and EU in four key areas:
- Appropriate antimicrobial use in human and veterinary medicine.
- Surveillance and prevention of AMR.
- Strategies to improve financial incentives, access, research, and development of antimicrobial drugs, diagnostics and alternatives.
- Cross-cutting actions to improve awareness and disseminate information from TATFAR.
Read more about this network: TATFAR